Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin

Southern Medical Journal

Volumn 101, Issue 5, 2008, Pages 539-540

  Ang, Jocelyn Y ^a   Asmar, Basim I ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Mandible; Moxifloxacin; Multidrug resistant viridans streptococcus (MDRVS); Osteomyelitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; MOXIFLOXACIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN V POTASSIUM; PREDNISONE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CELL COUNT; CASE REPORT; DEBRIDEMENT; ELECTROCARDIOGRAM; FEMALE; GRAFT REJECTION; HUMAN; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MANDIBLE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; ORAL BLEEDING; OSTEOMYELITIS; PNEUMOCYSTIS PNEUMONIA; TOOTH EXTRACTION;

ADULT; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; DEBRIDEMENT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; MANDIBULAR DISEASES; OSTEOMYELITIS; QUINOLINES; STREPTOCOCCAL INFECTIONS; VIRIDANS STREPTOCOCCI;

EID: 43149092233     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181684ee3     Document Type: Article

References (5)

1. Doern GV, Ferraro MJ, Brueggemann AB, et al. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40:891-894.
2. Dan M, Keynan O, Feldbrin Z, et al. Concentrations of moxifloxacin in serum and synovial fluid, and ex vivo bactericidal activity against arthritis-causing pathogens. Diagn Microbiol Infect Dis 2004;48:283-286.
3. Malincarne L, Ghebregzabher M, Moretti MV, et al. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty. J Antimicrob Chemother 2006;57:950-954.
4. Metallidis S, Charokopos N, Nikolaidis J, et al. Penetration of moxifloxacin into sternal bone of patients undergoing routine cardiopulmonary bypass surgery. Int J Antimicrob Agents 2006;28:428-432.
5. Frippiat F, Meunier F, Derue G. Place of newer quinolones and rifampicin in the treatment of Gram-positive bone and joint infections. J Antimicrob Chemother 2004;54:1158; author reply 1159.